Aether Industries IPO: The chemical company aims to raise Rs 808.04 crore through the IPO, which consists of a fresh issue of Rs 627 crore and an offer-for-sale of up to 2.82 million shares.
Aether Industries IPO: The chemicals company aims to raise Rs 808.04 crore from its public offer
Hem Securities has come out with its report on Aether Industries. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 23, 2022.
ICICI Direct has come out with its report on Aether Industries. The research firm has recommended to ''Avoid'' the ipo in its research report as on May 24, 2022.
Anand Rathi has come out with its report on Aether Industries. The research firm has recommended to ''Subscribe-Long term'' the ipo in its research report as on May 23, 2022.
eMudhra IPO: The company will use Rs 35 crore of the net proceeds to pre-pay or repay loans, while Rs 40.2 crore will be utilised to meet working capital requirements
The chemical company aims to raise Rs 808.04 crore from its public offer. Out of Rs 808.04 crore, company aims to raise Rs 627 crore through fresh issues.
Choice Equity Broking has come out with its report on Aether Industries. The research firm has recommended to ''Subscribe with Caution'' the ipo in its research report as on May 23, 2022.
Arihant Capital has come out with its report on Aether Industries. The research firm has recommended to ''Avoid'' the ipo in its research report as on May 23, 2022.
eMudhra IPO: The company had done a pre-IPO placement of 1,603,617 equity shares for a cash price of Rs 243.20 per equity share for an aggregate amount of Rs 39 crore to Baring Private Equity India AIF 2, Acacia Banyan Partners, Motilal Oswal Equity Opportunities Fund Series III, Negen Capital Services Private Limited, Value Wise Consultancy Private Limited, Jagadeesan Kumar, and Krishna Kumar.
eMudhra IPO: The company intends to utilize the net proceeds from the fresh issue to pre-pay or repay in part or full, the existing loans availed by the company to an extent of Rs 35 crore. Rs 40.2 crore will be used for funding its working capital requirements.
The company intends to garner about Rs 413 crore through fresh issue of equity shares upto Rs 161 crore and an offer for sale of of upto Rs 252 crore by the shareholders and promoters.
Choice Equity Broking has come out with its report on eMudhra. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 19, 2022.
The IPO, sized at Rs 413 crore, comprises fresh shares of Rs 161 crore and an offer for sale worth Rs 252 crore by shareholders and promoters.
The company aims to mop up Rs 1,501 crore in total from a fresh issue of shares worth Rs 1,004 crore and an offer for sale of Rs 497.73 crore
Arihant Capital has come out with its report on eMudhra. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 19, 2022.
Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 17, 2022.
Hem Securities has come out with its report on Ethos. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 17, 2022.
Ethos IPO: The company plans to garner Rs 472 crore through fresh issue of equity shares aggregating to Rs 375 crore and Rs 97.29 crore through the sale of 1,108,037 shares by the shareholders and promoters
Around 50 percent of the net offer will be reserved for QIBs, 35 percent for retail investors, and the remaining 15 percent for non-institutional investors.
The company aims to mop up Rs 1,501 crore by a combination of fresh issue of equity shares aggregating upto Rs 1,004 crore and an offer for sale (OFS) of 118,507,493 equity shares of Rs 10 each aggregating up to Rs 497.73 crore.
Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to ''Avoid'' the ipo in its research report as on May 14, 2022.
ICICI Direct has come out with its report on Ethos. The research firm has recommended to ''Avoid'' the ipo in its research report as on May 17, 2022.
Choice Equity Broking has come out with its report on Paradeep Phosphates. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 16, 2022.
Geojit has come out with its report on Paradeep Phosphates. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 16, 2022.